Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home
//Empty div tag to force external link icon image to appear

Influenza-associated pediatric mortality

2004 Case Definition


CSTE Position Statement(s)

  • 09-ID-44

Clinical Description

An influenza-associated death is defined for surveillance purposes as a death resulting from a clinically compatible illness that was confirmed to be influenza by an appropriate laboratory or rapid diagnostic test. There should be no period of complete recovery between the illness and death. Influenza-associated deaths in all persons aged <18 years should be reported.

A death should not be reported if:
  1. There is no laboratory confirmation of influenza virus infection.
  2. The influenza illness is followed by full recovery to baseline health status prior to death.
  3. The death occurs in a person 18 years or older.
  4. After review and consultation there is an alternative agreed upon cause of death.

Laboratory Criteria for Diagnosis

Laboratory testing for influenza virus infection may be done on pre- or post-mortem clinical specimens, and include identification of influenza A or B virus infections by a positive result by at least one of the following:
  • Influenza virus isolation in tissue cell culture from respiratory specimens;
  • Reverse-transcriptase polymerase chain reaction (RT-PCR) testing of respiratory specimens;
  • Immunofluorescent antibody staining (direct or indirect) of respiratory specimens;
  • Rapid influenza diagnostic testing of respiratory specimens;
  • Immunohistochemical (IHC) staining for influenza viral antigens in respiratory tract tissue from autopsy specimens;
  • Four-fold rise in influenza hemagglutination inhibition (HI) antibody titer in paired acute and convalescent sera*.

Case Classification

Confirmed

A death meeting the clinical definition that is laboratory confirmed.

Laboratory or rapid diagnostic test confirmation is required as part of the case definition; therefore, all reported deaths will be classified as confirmed.

Comment(s)

*Serologic testing for influenza is available in a limited number of laboratories, and should only be considered as evidence of recent infection if a four-fold rise in influenza (HI) antibody titer is demonstrated in paired sera. Single serum samples are not interpretable.

The 2004 case definition appearing on this page was re-published in the 2009 CSTE position statement 09-ID-44. Thus, the 2004 and 2010 versions of the case definition are identical.




logo for phConnect web site


CDC Vital Signs™ – Learn about the latest public health data. Read CDC Vital Signs™…

Contact Us:
  • National Notifiable Diseases Surveillance System
    Division of Health Informatics and Surveillance (DHIS)
    Centers for Disease Control and Prevention
    1600 Clifton Rd
    Mail Stop E-91
    Atlanta, GA 30333 USA
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • NNDSSWeb@cdc.gov
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #